星空体育官方入口网站网址大全-登录入口官网

#Xa因子抑制剂#

8篇内容 | 959人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2215040, encodeId=28a0221504080, content=<a href='/topic/show?id=dd85431162e' target=_blank style='color:#2F92EE;'>#多发性骨髓瘤#</a> <a href='/topic/show?id=c3cc35912aa' target=_blank style='color:#2F92EE;'>#华法林#</a> <a href='/topic/show?id=5ad518e987f' target=_blank style='color:#2F92EE;'>#Xa因子抑制剂#</a> <a href='/topic/show?id=74fb291e85c' target=_blank style='color:#2F92EE;'>#免疫调节剂#</a>, objectTitle=免疫调节剂治疗的MM模型血栓形成预防：Xa因子抑制剂华法林, objectType=article, longId=834650, objectId=82008346502e, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/202301017/1697523836362_2570354.jpg, objectUrl=/article/show_article.do?id=82008346502e, replyNumber=0, likeNumber=25, createdTime=2024-07-15, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=82008346502e, moduleTitle=免疫调节剂治疗的MM模型血栓形成预防：Xa因子抑制剂华法林, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=82008346502e)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=1777365, encodeId=a6361e7736527, content=<a href='/topic/show?id=5ad518e987f' target=_blank style='color:#2F92EE;'>#Xa因子抑制剂#</a>, objectTitle=Physiol Rep：FXa因子抑制剂艾多沙班可通过减少上皮间质转化和炎症反应来改善肾大部分切除术后的肾损伤, objectType=article, longId=301747, objectId=284b301e47e0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=284b301e47e0, replyNumber=0, likeNumber=73, createdTime=2022-05-16, rootId=0, userName=hxzhang, userId=d13c39165560, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=284b301e47e0, moduleTitle=Physiol Rep：FXa因子抑制剂艾多沙班可通过减少上皮间质转化和炎症反应来改善肾大部分切除术后的肾损伤, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=284b301e47e0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1777364, encodeId=f4e81e7736401, content=<a href='/topic/show?id=5ad518e987f' target=_blank style='color:#2F92EE;'>#Xa因子抑制剂#</a>, objectTitle=Circulation：凝血酶原复合浓缩物（PCC）用于Xa因子抑制剂相关性颅内出血的止血效果及安全性, objectType=article, longId=195570, objectId=1c181955e05c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1c181955e05c, replyNumber=0, likeNumber=91, createdTime=2020-06-21, rootId=0, userName=hxzhang, userId=d13c39165560, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1c181955e05c, moduleTitle=Circulation：凝血酶原复合浓缩物（PCC）用于Xa因子抑制剂相关性颅内出血的止血效果及安全性, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=1c181955e05c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1777363, encodeId=fc7b1e77363c9, content=<a href='/topic/show?id=5ad518e987f' target=_blank style='color:#2F92EE;'>#Xa因子抑制剂#</a>, objectTitle=IJLH：体外研究依诺肝素对直接口服Xa因子抑制剂血药浓度的影响, objectType=article, longId=175929, objectId=a8ba1e5929f4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a8ba1e5929f4, replyNumber=0, likeNumber=73, createdTime=2019-10-28, rootId=0, userName=hxzhang, userId=d13c39165560, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a8ba1e5929f4, moduleTitle=IJLH：体外研究依诺肝素对直接口服Xa因子抑制剂血药浓度的影响, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=a8ba1e5929f4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1777362, encodeId=df4e1e7736208, content=<a href='/topic/show?id=5ad518e987f' target=_blank style='color:#2F92EE;'>#Xa因子抑制剂#</a>, objectTitle=NEJM：Andexanet用于Xa因子抑制剂后出血的止血效果研究, objectType=article, longId=159832, objectId=ad501598321d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ad501598321d, replyNumber=0, likeNumber=56, createdTime=2019-10-14, rootId=0, userName=hxzhang, userId=d13c39165560, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ad501598321d, moduleTitle=NEJM：Andexanet用于Xa因子抑制剂后出血的止血效果研究, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=ad501598321d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1777361, encodeId=3f0e1e773615c, content=<a href='/topic/show?id=5ad518e987f' target=_blank style='color:#2F92EE;'>#Xa因子抑制剂#</a>, objectTitle=ACC 2018：ANNEXA-4研究：Xa因子抑制剂的“解药”即将登场, objectType=article, longId=132725, objectId=fcf8132e2506, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fcf8132e2506, replyNumber=0, likeNumber=64, createdTime=2019-02-28, rootId=0, userName=hxzhang, userId=d13c39165560, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fcf8132e2506, moduleTitle=ACC 2018：ANNEXA-4研究：Xa因子抑制剂的“解药”即将登场, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=fcf8132e2506)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1777360, encodeId=f6c71e77360e6, content=<a href='/topic/show?id=5ad518e987f' target=_blank style='color:#2F92EE;'>#Xa因子抑制剂#</a>, objectTitle=NEJM：Andexanet Alfa可逆转Xa因子抑制剂的活性, objectType=article, longId=60767, objectId=65ff60e67cf, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=65ff60e67cf, replyNumber=0, likeNumber=72, createdTime=2016-07-06, rootId=0, userName=hxzhang, userId=d13c39165560, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=65ff60e67cf, moduleTitle=NEJM：Andexanet Alfa可逆转Xa因子抑制剂的活性, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=65ff60e67cf)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1777359, encodeId=59bd1e77359f8, content=<a href='/topic/show?id=5ad518e987f' target=_blank style='color:#2F92EE;'>#Xa因子抑制剂#</a>, objectTitle=JAMA：Xa因子抑制剂预防房颤患者卒中优于华法林, objectType=article, longId=32477, objectId=ac04324e75c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ac04324e75c, replyNumber=0, likeNumber=62, createdTime=2014-11-13, rootId=0, userName=hxzhang, userId=d13c39165560, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ac04324e75c, moduleTitle=JAMA：Xa因子抑制剂预防房颤患者卒中优于华法林, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=ac04324e75c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1777358, encodeId=02c21e77358e5, content=<a href='/topic/show?id=5ad518e987f' target=_blank style='color:#2F92EE;'>#Xa因子抑制剂#</a>, objectTitle=NEJM：口服直接Xa因子抑制剂治疗急性症状性肺栓塞患者, objectType=article, longId=12343, objectId=89ad123436c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=89ad123436c, replyNumber=0, likeNumber=69, createdTime=2013-06-15, rootId=0, userName=hxzhang, userId=d13c39165560, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=89ad123436c, moduleTitle=NEJM：口服直接Xa因子抑制剂治疗急性症状性肺栓塞患者, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=89ad123436c)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

Xa因子抑制剂

2020-05-29

梅斯管理员 (审核中...)

前往app查看评论内容

#多发性骨髓瘤# #华法林# #Xa因子抑制剂# #免疫调节剂#

免疫调节剂治疗的MM模型血栓形成预防：Xa因子抑制剂华法林

2024-07-15发表于上海

hxzhang (审核中...)

前往app查看评论内容

#Xa因子抑制剂#

Physiol Rep：FXa因子抑制剂艾多沙班可通过减少上皮间质转化和炎症反应来改善肾大部分切除术后的肾损伤

2022-05-16

hxzhang (审核中...)

前往app查看评论内容

#Xa因子抑制剂#

Circulation：凝血酶原复合浓缩物（PCC）用于Xa因子抑制剂相关性颅内出血的止血效果及安全性

2020-06-21

hxzhang (审核中...)

前往app查看评论内容

#Xa因子抑制剂#

IJLH：体外研究依诺肝素对直接口服Xa因子抑制剂血药浓度的影响

2019-10-28

hxzhang (审核中...)

前往app查看评论内容

#Xa因子抑制剂#

NEJM：Andexanet用于Xa因子抑制剂后出血的止血效果研究

2019-10-14

hxzhang (审核中...)

前往app查看评论内容

#Xa因子抑制剂#

ACC 2018：ANNEXA-4研究：Xa因子抑制剂的“解药”即将登场

2019-02-28

hxzhang (审核中...)

前往app查看评论内容

#Xa因子抑制剂#

NEJM：Andexanet Alfa可逆转Xa因子抑制剂的活性

2016-07-06

hxzhang (审核中...)

前往app查看评论内容

#Xa因子抑制剂#

JAMA：Xa因子抑制剂预防房颤患者卒中优于华法林

2014-11-13

hxzhang (审核中...)

前往app查看评论内容

#Xa因子抑制剂#

NEJM：口服直接Xa因子抑制剂治疗急性症状性肺栓塞患者

2013-06-15

科室
- - 订阅+
  - 更多科室
工具
服务